Overview

CSTC1 for Diabetic Foot Ulcers Phase II Study

Status:
Completed
Trial end date:
2020-01-07
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of CSTC1 in patient with diabetic foot ulcers.
Phase:
Phase 2
Details
Lead Sponsor:
Charsire Biotechnology Corp.
Collaborator:
ASKLEP Inc.